Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals

Area of Science:

• Endocrinology
• Metabolic Diseases
• Proteomics

Background:

• Islet dysfunction is central to type 2 diabetes mellitus (T2DM) pathogenesis.
• Understanding the molecular mechanisms of T2DM-related islet failure is crucial but limited by sample scarcity.
• Human T2DM islets offer a unique model for studying disease pathophysiology.

Purpose of the Study:

• To identify cellular mechanisms underlying T2DM pathophysiology.
• To compare protein expression profiles in islets from T2DM individuals and healthy controls.
• To analyze differential pathway activation in T2DM islets.

Main Methods:

• Proteomic analysis of human islets using liquid chromatography-Fourier transform ion resonance mass spectrometry (LC-FTICR-MS) and surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS).
• Comparative analysis of protein expression and pathway activation between T2DM and control islets.
• Bioinformatic analysis to identify differentially activated and inactivated signaling pathways.

Main Results:

• Multiple differentially expressed proteins in T2DM islets correlated with impaired insulin secretion.
• Activated pathways in T2DM islets included cell arrest/apoptosis (p53, caspase, stress-activated) and immune response (Fas).
• Proliferation and regeneration pathways (E2F) were activated, while others (insulin, PRL, PDGF) were inactivated in T2DM islets.

Conclusions:

• This study provides the first report of differential pathway signaling patterns in deteriorating T2DM islets.
• Identified pathway alterations highlight a complex interplay of apoptosis, cell cycle regulation, and regeneration.
• Understanding these signaling changes may lead to novel strategies for restoring islet cell function and survival in T2DM.